Cited by 35Cancer-related Molecular PathwaysDevelopmental Biology and Gene RegulationChromatin Remodeling and Cancer

Genes in the RB pathway and their knockout in mice

Lin, Suh-Chin J., Skapek, Stephen X., Lee, Eva Y.-H.P.·1996·Seminars in Cancer Biology

Abstract

The retinoblastoma susceptibility gene (RB), the first identified human tumor suppressor gene, has been shown to be directly involved in the genesis of a variety of human cancers. RB is actually one of a family of three closely related genes including p107 and p130. Many elegant biochemical studies have demonstrated that RB is a critical component of the cell cycle regulatory machinery and have characterized the downstream effectors which the RB gene product regulates. More recent advances have demonstrated that the function of RB and RB-related genes is positively and negatively regulated by an intricate network of cell cycle regulatory proteins, some of which have also been implicated as tumor suppressor genes. Despite the detailed understanding of these biochemical and genetic pathways, the full function of genes in the RB pathway in the context of a whole organism is only now being addressed. Using gene knockout technology, it is now known that RB, and RB-related proteins p107 and p130, have important functions during early mouse development. Furthermore, despite its ubiquitous expression, RB has tissue- and cell-type specific effects which account for its function as a tumor suppressor but may also be independent of its role as a cell cycle regulator. Analysis of mice lacking regulatory genes upstream of RB and effector genes downstream of RB have confirmed that other genes in this pathway have tissue-specific effects on development and tumor susceptibility in mice.

Integrity signals

Registry

Crossref · 10.1006/scbi.1996.0036

Cites

Statistics

Recomputing p-values needs the paper’s full text.

Claims the paper makes

This paper’s full text isn’t openly available, so its claims and self-check weren’t run. The registry and citation checks still apply.

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

  • Mutations in p16, Rb, ARF and TP53 are frequently found in human cancers.

    “Mutations in p16 , Rb , ARF and TP53 are frequently found in human cancers, and their tumour-suppressive roles have been confirmed in vivo using genetically modified mouse models [25 -29].”
  • The tumour-suppressive roles of p16, Rb, ARF and TP53 have been confirmed in vivo using genetically modified mouse models.

    “Mutations in p16 , Rb , ARF and TP53 are frequently found in human cancers, and their tumour-suppressive roles have been confirmed in vivo using genetically modified mouse models [25 -29].”

Cited by

Sorted by citations

Authors
Lin, S.-C. J., Skapek, S. X., & Lee, E. Y.-H. P.
Affiliations
The University of Texas at San Antonio Health Science Center (US)
Venue
Seminars in Cancer Biology
Publisher
Elsevier BV
Published
1996-10
Volume
7
Issue
5
Pages
279-289
ISSN
1044-579X (ISSN-L)
OpenAlex
W2068778750
Cited by
35
References
0
Citations by year
2025: 1 · 2024: 1 · 2022: 2 · 2021: 1 · 2020: 1 · 2017: 1 · 2016: 1 · 2015: 1 · 2014: 1 · 2013: 1
FWCI
1.05
Type
journal article
Language
en
Open access
closed
Locations
  • Seminars in Cancer Biology (publishedVersion)
  • PubMed (publishedVersion)
Topics
  • Health Sciences › Medicine › Oncology › Cancer-related Molecular Pathways
  • Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Developmental Biology and Gene Regulation
  • Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Chromatin Remodeling and Cancer
Keywords
retinoblastoma gene, Rb pathway, p107, p130, tumor suppressor, cell cycle regulation, knockout mice, mouse development, tissue-specific gene function, cancer susceptibility
MeSH terms
Animals, Humans, Retinoblastoma Protein, Genes, Retinoblastoma, Mice, Knockout, Mice

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review